ConvaTec Group PLC (LON:CTEC) Insider Sells £338,567.68 in Stock

ConvaTec Group PLC (LON:CTECGet Free Report) insider Karim Bitar sold 132,253 shares of the firm’s stock in a transaction on Friday, March 14th. The shares were sold at an average price of GBX 256 ($3.32), for a total value of £338,567.68 ($439,014.11).

Karim Bitar also recently made the following trade(s):

  • On Monday, March 17th, Karim Bitar sold 436,692 shares of ConvaTec Group stock. The shares were sold at an average price of GBX 256 ($3.32), for a total value of £1,117,931.52 ($1,449,600.00).

ConvaTec Group Trading Up 0.4 %

ConvaTec Group stock opened at GBX 258.17 ($3.35) on Friday. The stock has a market cap of £6.57 billion, a PE ratio of 43.48, a P/E/G ratio of 0.93 and a beta of 0.64. The stock has a 50-day moving average price of GBX 247.69 and a 200 day moving average price of GBX 234.80. ConvaTec Group PLC has a 52 week low of GBX 211.80 ($2.75) and a 52 week high of GBX 295.20 ($3.83). The company has a current ratio of 2.26, a quick ratio of 0.96 and a debt-to-equity ratio of 85.32.

ConvaTec Group Increases Dividend

The business also recently disclosed a dividend, which will be paid on Thursday, May 29th. Investors of record on Thursday, April 17th will be given a dividend of $0.05 per share. This represents a yield of 1.36%. The ex-dividend date is Thursday, April 17th. This is a boost from ConvaTec Group’s previous dividend of $0.02. ConvaTec Group’s dividend payout ratio (DPR) is currently 84.20%.

Analysts Set New Price Targets

Separately, Berenberg Bank restated a “buy” rating and issued a GBX 310 ($4.02) price target on shares of ConvaTec Group in a research report on Wednesday, March 5th.

Read Our Latest Research Report on ConvaTec Group

About ConvaTec Group

(Get Free Report)

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.

Featured Articles

Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.